ARQT — Arcutis Biotherapeutics, Inc.
15 mentions in the last 24 hours · 0.07% of all mentions
Why people talked about ARQT (2026-11-05)
- Arcutis Biotherapeutics reported Q3 2026 results with EPS of $0.06, missing estimates by $0.10.
- Revenue reached $143.9M, beating the $142.4M estimate by $1.31M.
- The company issued a Form 8-K press release regarding these financial results on November 4, 2026.
| Bluesky | 12 | community |
| GDELT | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |